Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 28 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
271 22.6 months Metastatic, castration-resistant prostate cancer 5 Biologic therapy
Chemotherapy
Hormone
Thomas Jefferson University United States 3/2012
Treatment Details: Patients: This phase III study involved men with previously untreated (other than surgery) metastatic castration-resistant prostate cancer who were divided into two separate treatment group
 
272 22.5 months Recurrent ovarian cancer 5 Chemotherapy
Cedars-Sinai Medical Center United States 2/2012
Treatment Details: Patients: This study involved women with recurrent ovarian cancer who were separated into two separate treatment groups. Group A had 53 patients with a median age of 59 years. Group B had
 
273 22.5 months Hepatocellular carcinoma 4 Chemotherapy
Veneto Institute of Oncology Italy 1/2011
Treatment Details: Patients: This phase 2 study involved 41 patients with hepatocellular carcinoma who had not received prior chemotherapy for this disease. The median patient age was 63.2 years and 80.5% we
 
274 22.5 months Metastatic breast cancer 5 Chemotherapy
UCLA Medical Center United States 3/2003
Treatment Details: Patients: This Phase III study involved a total of 429 patients with metastatic breast cancer. Patients were divided into two groups – group 1 comprised 214 patients (213 received treatment
 
275 22.5 months Metastatic breast cancer 5 Chemotherapy
Indiana University Medical Center United States 2/2003
Treatment Details: Patients: This Phase III trial involved 731 patients with metastatic breast cancer. Patients were divided into three groups: Group A contained 245 patients, Group B contained 242 patients,
 
276 22.4 months Metastatic breast cancer 5 Chemotherapy
Indiana University Medical Center United States 2/2003
Treatment Details: Patients: This Phase III trial involved 731 patients with metastatic breast cancer. Patients were divided into three groups: Group A contained 245 patients, Group B contained 242 patients,
 
277 22.4 months Metastatic colorectal cancer 4 Biologic therapy
Chemotherapy
Hôpital Ambroise Paré France 4/2009
Treatment Details: Patients: This study involved 52 patients with EGFR-detectable metastatic colorectal cancer. The median age of the patients was 61 years, and 63.5% were male. Treatment: Patients were
 
278 22.4 months Metastatic breast cancer 4 Chemotherapy
University General Hospital of Heraklion Greece 9/2011
Treatment Details: Patients: This phase III study involved women with metastatic breast cancer who had previously received chemotherapy. These patients were divided into two separate treatment groups. Group
 
279 22.4 months GBM 4 Chemotherapy
Immunotherapy
Radiation
University of Tsukuba Japan 7/2014
Treatment Details: Patients: This phase 2 study involved 24 glioblastoma multiforme patients who had not received prior chemotherapy. The average patient age was 48 years and 17 were male. Treatment: Pat
 
280 22.4 months NHL 4 Biologic therapy
Chemotherapy
Hormone
Fujian Medical University China 11/2014
Treatment Details: Patients: This study involved 16 refractory or relapsed aggressive non-Hodgkin’s lymphoma patients who were in a state of poor health. The median patient age was 55 years and 11 were male.
 
Page 28 of 187  | Previous Page  | Next Page